H6F is an altered peptide ligand that significantly augments CD8+CD25+Fop3+ T-cells in the spleen and pancreas, exhibiting effective inhibition of specific CD8+ Treg cell response in T1D models [90, 91]. The gene discussed is CD8A; the disease is type 1 diabetes mellitus.